| abstract |
Provided is a novel cancer marker for testing the risk of developing a cancer.　This cancer marker includes at least one substance selected from the group consisting of anti-HIRIP3 antibodies, HIRIP3, anti-FNDC11 antibodies, FNDC11, anti-SLC1A3 antibodies, SLC1A3, anti-TMEM33 antibodies, TMEM33, anti-ABCF1 antibodies, ABCF1, anti-CFDP1 antibodies, CFDP1, anti-POLR3GL antibodies, POLR3GL, anti-CADM1 antibodies, CADM1, anti-RNF128 antibodies, RNF128, anti-ATP6V1B1 antibodies, and ATP6V1B1. |